High efficacy of anti-TFR1 antibody against the growth of mogamulizmab-resistant ATLL cells

Shingo Nakahata

Presentation information

Poster Session

Sat. Oct, 13

Poster Session 2-15 NK/T cell lymphoma: Basic

Sat. Oct 13, 2018 5:10 PM - 5:50 PM Poster1 (Osaka International Convention Center, 3F Event Hall)

Chair: Asahi Ito (Depaertment of Hematology and Oncology, Nagoya City University)

[PS2-15-3] High efficacy of anti-TFR1 antibody against the growth of mogamulizmab-resistant ATLL cells

Shingo Nakahata¹, Shunsuke Shimosaki¹, Tomonaga Ichikawa¹, Takuro Kameda², Tomonori Hidaka², Yoko Kubuki², Gene Kurosawa³, Kazuya Shimoda², Kazuhiro Morishita¹ (1.Div. Tumor&Cell. Biochem., Dept. Med. Sci., Miyazaki Univ., 2.Div. Gastroenterol.&Hematol., Dept. Int. Med., Miyazaki Univ., Miyazaki, Japan, 3.Div. Antibody Project, Fujita Health University, Toyoake, Japan)

Abstract password authentication.
Password is written on a program and abstract book.